id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-E-0164-0004,FDA,FDA-2009-E-0164,U.S. Patent and Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2009-12-08T05:00:00Z,2009,12,2009-12-08T05:00:00Z,,2013-07-27T23:01:45Z,,0,0,0900006480a667cf
FDA-2009-E-0164-0003,FDA,FDA-2009-E-0164,FDA/CDER to the U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2009-10-01T04:00:00Z,2009,10,2009-10-01T04:00:00Z,,2009-10-01T18:56:47Z,,0,0,0900006480a366cc
FDA-2009-E-0164-0002,FDA,FDA-2009-E-0164,Genzyme Corporation - Patent Term Extension Application,Other,APP-Application,2009-03-27T04:00:00Z,2009,3,2009-03-27T04:00:00Z,,2009-03-27T19:32:45Z,,0,0,0900006480933a98
FDA-2009-E-0164-0001,FDA,FDA-2009-E-0164,U.S. Patent and Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2009-03-27T04:00:00Z,2009,3,2009-03-27T04:00:00Z,,2009-03-27T19:32:43Z,,0,0,0900006480933a81